首页> 外文OA文献 >PUK13 Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

【2h】

PUK13 Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

机译：PUK13固定剂量联合索非那新联合坦索罗辛Ocas治疗西班牙良性前列腺增生引起的下尿路症状的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Toledo A; Llopis A; Mora A; Rubio-Terrés C; Rubio-Rodríguez D; Nazir J;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia [J] . Jameel Nazir, Lars Heemstra, Anke van Engen, BMC Urology . 2015,第1期

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状的男性中的成本效益
2. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in?patients with benign prostatic hyperplasia [J] . Konstantinos Dimitropoulos, Stavros Gravas Drug Design, Development and Therapy . 2015,第5期

机译：Solifenacin / tamsulosin固定剂量联合治疗良性前列腺增生患者的下尿路症状
3. The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia [J] . Elbadry Mohamed, Ali Ahmed Issam, Saleh Eman, African journal of urology . 2020,第1期

机译：将Solifencin添加到Tamsulosin疗法中，治疗储存降低尿路症状的影响，因为良性前列腺增生
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. [D] . DiSantostefano, Rachael Lynn. 2005

机译：良性前列腺增生治疗的长期成本效益。
6. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia [O] . Jameel Nazir, Lars Heemstra, Anke van Engen, 2015

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状患者中的成本效益
7. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia [O] . Jameel Nazir, Lars Heemstra, Anke van Engen, 2015

机译：索非那新固定剂量组合和坦洛新口服控制吸附系统口服制剂在伴有前列腺增生的下尿路症状的男性中的成本效益

PUK13 Cost-Effectiveness Of A Fixed-Dose Combination Of Solifenacin Plus Tamsulosin Ocas For The Treatment Of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia In Spain

著录项

引文网络

相似文献

相关主题

期刊订阅